SCHEMBL4820239

SCHEMBL4820239

[CH2]CC(c1ccccc1)C(c1ccccc1)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 2/20 0.41
SLC6A4 P31645 3/20 0.39
SLC6A3 Q01959 3/20 0.39
SLC6A2 P23975 2/20 0.39
HTR2A P28223 2/20 0.39
DPP4 P27487 2/20 0.36
TSHR P16473 2/20 0.36
F2 P00734 1/20 0.36
HRH1 P35367 2/20 0.36
MTOR P42345 1/20 0.36
RAB9A P51151 1/20 0.36
GRM7 Q14831 1/20 0.36
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
HKDC1 Q2TB90 1/20 0.35
CES2 O00748 1/20 0.34
CES1 P23141 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6325160 0.78 TAAR1 (0.61) TAAR1SLC6A4SLC6A3SLC6A2HTR2A
SCHEMBL3861713 0.77 HKDC1 (0.55) TAAR1SLC6A4SLC6A3SLC6A2HTR2A
SCHEMBL11529211 0.76 DPP4 (0.56) TAAR1SLC6A4SLC6A3SLC6A2HTR2A
SCHEMBL3624306 0.76 TAAR1 (0.48) TAAR1SLC6A4SLC6A3SLC6A2HTR2A
SCHEMBL11478651 0.76 HKDC1 (0.55) TAAR1SLC6A4SLC6A3SLC6A2HTR2A
SCHEMBL5998357 0.75 TAAR1 (0.64) TAAR1SLC6A4SLC6A3SLC6A2HTR2A
Ammonia Solution, Strong SCHEMBL18191766 0.75 HKDC1 (0.53) TAAR1SLC6A4SLC6A3SLC6A2HTR2A
SCHEMBL28511682 0.75 TAAR1 (0.52) TAAR1SLC6A4SLC6A3SLC6A2HTR2A
SCHEMBL4892666 0.74 CES2 (0.42) TAAR1HTR2ADPP4TSHRF2
SCHEMBL7958722 0.73 TACR1 (0.43) TAAR1SLC6A4SLC6A3SLC6A2HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7425580-B2 (Diaryl-methyl)-malononitriles and their use as estrogen receptor ligands WYETH (US) 2008-09-16 US disclosed
US-20060014831-A1 (Diaryl-methyl)-malononitriles and their use as estrogen receptor ligands WYETH (US) 2006-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060014831-A1 (Diaryl-methyl)-malononitriles and their use as estrogen receptor ligands ESR1, ESR2, GPER1 TAAR1 404/4885SLC6A4 3720/4885SLC6A3 3526/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.